Next generation maleimides enable the controlled assembly of antibody–drug conjugates via native disulfide bond bridging

The advent of Adcetris™ and Kadcyla™, two recently FDA-approved antibody–drug conjugates (ADCs), in the clinic has had a major impact on the treatment of lymphoma and breast cancer patients, respectively, worldwide. Despite these successes many new ADCs fail at various stages of development, often d...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Schumacher, Felix F., Nunes, João P. M., Maruani, Antoine, Chudasama, Vijay, Smith, Mark E. B., Chester, Kerry A., Baker, James R., Caddick, Stephen
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Royal Society of Chemistry 2014
Onderwerpen:
Chemistry
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4159697/
https://ncbi.nlm.nih.gov/pubmed/25103319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c4ob01550a
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items